AMBROSIA BIOSCIENCES INC.

Profile

Company Names

AMBROSIA BIOSCIENCES INC.

Addresses

1941 PEARL STREET, SUITE 300, BOULDER, CO 80302

Phone Numbers

(303) 351-5800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2024

State Incorporated:

DELAWARE

Total Amount Raised:

$15,955,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-07-23 
$15,955,000.00 
$25,000,000.00 
$9,045,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KYLE 
 
LEFKOFF 
DIRECTOR
HIBERNA CORP   |  CENTERSTONE TECHNOLOGIES INC   |  MIRAGEN THERAPEUTICS INC   |  BIOPTIX DIAGNOSTICS, INC.   |  LINERATE SYSTEMS, INC.   |  MARKET FORCE INFORMATION INC   |  PROFOLDRX, INC.   |  BAROFOLD, INC.   |  COMMERCIALTRIBE INC.   |  MIRAGEN THERAPEUTICS, INC.   |  BLACK BEAR ENERGY, INC.   |  ARCHERDX, INC.   |  BOULDER VENTURES VIII, L.P.   |  BOULDER VENTURES VIII (ANNEX), L.P.   |  AMBROSIA BIOSCIENCES INC.
WILLIAM 
S. 
MARSHALL 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  PLANET LABS INC.   |  MIRAGEN THERAPEUTICS, INC.   |  MIRAGEN THERAPEUTICS, INC.   |  AMBROSIA BIOSCIENCES INC.
JOHN 
S. 
ORWIN 
DIRECTOR
AMBROSIA BIOSCIENCES INC.
DAVID 
S. 
SNITMAN 
DIRECTOR
AMBROSIA BIOSCIENCES INC.
NICHOLAS 
 
TRAGGIS 
EXECUTIVE OFFICER, DIRECTOR
AMBROSIA BIOSCIENCES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-23 
2024-08-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#